• English
  • Korean
  • Chinese
表紙
市場調査レポート - 201130

神経刺激装置:世界のパイプライン分析・競合展望および2018年までの市場予測

Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

発行 GlobalData
出版日 ページ情報 英文 99 Pages
電子版即納可
価格
神経刺激装置:世界のパイプライン分析・競合展望および2018年までの市場予測 Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
出版日: 2012年06月30日 ページ情報: 英文 99 Pages
概要

全世界の神経刺激装置の市場規模は、2011年には23億米ドル、2018年には44億米ドルに達する(2011〜2018年の年平均成長率は10%)、と予測されています。慢性痛・パーキンソン病・てんかんといった発症件数が増加している疾患での治療のため需要が、成長を促進させるものと思われます。

当レポートでは、神経刺激装置の世界市場について分析し、市場全体の構造や、総収益の実績値・予測値(2004〜2018年)、部門別・国別の詳細動向、主要企業のプロファイル、パイプライン製品、資本取引動向などの情報を盛り込んで、その結果を概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 疾患の概要

  • 慢性痛
    • 神経刺激で治療できる慢性痛の種類
    • 疫学
    • 治療
  • パーキンソン病
    • 疫学
    • 治療
  • てんかん
    • 疫学
    • 治療

第4章 神経刺激装置への医療費還付

  • 脊髄刺激装置
  • 脳深部刺激装置
  • 仙骨神経刺激装置
  • 迷走神経刺激装置
  • 「人道的医療機器」(Humanitarian Use Devices)としての神経刺激装置への医療費還付
  • メディケア(Medicare)・メディケイド(Medicaid)サービスセンターの医療費支払い方式の変更
    • 通院外科診療所(Ambulatory Surgical Center)の利用料金率
    • メディケアの外来患者向け医療費(2011年)

第5章 神経刺激装置の概要

  • 市場の分類
    • 脊髄刺激装置
    • 脳深部刺激装置
    • 仙骨神経刺激装置
    • 迷走神経刺激装置
    • 皮質刺激装置市場

第6章 世界市場の特徴

  • 市場収益実績値(2004〜2011年)
  • 市場収益予測値(2011〜2018年)
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因

第7章 各国市場の分析:市場収益(2004〜2018年)

  • 市場収益の実績値・予測値:米国(2004〜2018年)
  • 市場収益の実績値・予測値:カナダ(2004〜2018年)
  • 市場収益の実績値・予測値:英国(2004〜2018年)
  • 市場収益の実績値・予測値:ドイツ(2004〜2018年)
  • 市場収益の実績値・予測値:フランス(2004〜2018年)
  • 市場収益の実績値・予測値:イタリア(2004〜2018年)
  • 市場収益の実績値・予測値:スペイン(2004〜2018年)
  • 市場収益の実績値・予測値:日本(2004〜2018年)
  • 市場収益の実績値・予測値:中国(2004〜2018年)
  • 市場収益の実績値・予測値:インド(2004〜2018年)
  • 市場収益の実績値・予測値:オーストラリア(2004〜2018年)
  • 市場収益の実績値・予測値:ブラジル(2004〜2018年)

第8章 戦略的競合企業評価

  • 企業シェア(全世界、2011年)
  • Medtronic
  • St Jude Medical
  • Boston Scientific
  • Cyberonics

第9章 パイプライン評価

  • 脊髄刺激装置のパイプライン製品(全7件)
  • 脳深部刺激装置のパイプライン製品(全11件)
  • 仙骨神経刺激装置のパイプライン製品(全3件)
  • 迷走神経刺激装置のパイプライン製品(全4件)
  • 皮質刺激装置市場のパイプライン製品(全1件:Cortistim)
  • その他のパイプライン上の神経刺激装置

第10章 取引分析

  • 企業合併・買収(全4件)
  • ベンチャーキャピタル取引(全11件)
  • パートナーシップ取引(全3件)

第11章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Abstract

Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData's new report, "Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global neurostimulation devices market. It outlines the market landscape and provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered are the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Key segments covered are spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators and cortical stimulators.
  • Annualized market revenues data from 2004 to 2011, forecast to 2018, and company share data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints by category within the neurostimulation devices market.
  • Information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Medtronic, St. Jude Medical, Boston Scientific Corporation and Cyberonics.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the neurostimulation devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
  • What is the next big thing in the neurostimulation devices market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global neurostimulation devices market and the factors shaping it.

TOC

1 Table of Contents

1 Table of Contents 4

  • 1.1 List of Tables 7
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 GlobalData Report Guidance 10

3 Disease Overview 11

  • 3.1 Chronic Pain 11
    • 3.1.1 Types of Chronic Pain Treated with Neurostimulation 11
    • 3.1.2 Epidemiology 12
    • 3.1.3 Treatment 12
  • 3.2 Parkinson's Disease 13
    • 3.2.1 Epidemiology 13
    • 3.2.2 Treatment 14
  • 3.3 Epilepsy 14
    • 3.3.1 Epidemiology 14
    • 3.3.2 Treatment 15

4 Reimbursement for Neurostimulation Devices 16

  • 4.1 Spinal Cord Stimulators 16
  • 4.2 Deep Brain Stimulators 16
  • 4.3 Sacral Nerve Stimulators 17
  • 4.4 Vagus Nerve Stimulators 17
  • 4.5 Reimbursement for Neurostimulators Developed as Humanitarian Use Devices 17
  • 4.6 Centers for Medicare and Medicaid Services Payment Changes, 2011 18
    • 4.6.1 Ambulatory Surgical Center Payment System Rates, 2011 18
    • 4.6.2 US Medicare Hospital Outpatient Payment Rates, 2011 19

5 Device Overview - Neurostimulation Devices 20

  • 5.1 Market Segmentation 20
    • 5.1.1 Spinal Cord Stimulators 20
    • 5.1.2 Deep Brain Stimulators 20
    • 5.1.3 Sacral Nerve Stimulators 20
    • 5.1.4 Vagus Nerve Stimulators 21
    • 5.1.5 Cortical Stimulators 21

6 Neurostimulation Devices Market - Global Market Characterization 22

  • 6.1 Neurostimulation Devices Market, Global, Revenue ($m), Historic, 2004-2011 22
  • 6.2 Neurostimulation Devices Market, Global, Revenue ($m), Forecast, 2011-2018 23
  • 6.3 Neurostimulation Devices, Market Dynamics 24
    • 6.3.1 Market Drivers 24
    • 6.3.2 Market Restraints 29

7 Neurostimulation Devices Market, Revenue ($m), by Country, 2004-2018 30

  • 7.1 Neurostimulation Devices Market, The US, Revenue ($m), Historic, 2004-2011 30
  • 7.2 Neurostimulation Devices Market, The US, Revenue ($m), Forecast, 2011-2018 31
  • 7.3 Neurostimulation Devices Market, Canada, Revenue ($m), Historic, 2004-2011 32
  • 7.4 Neurostimulation Devices Market, Canada, Revenue ($m), Forecast, 2011-2018 33
  • 7.5 Neurostimulation Devices Market, The UK, Revenue ($m), Historic, 2004-2011 34
  • 7.6 Neurostimulation Devices Market, The UK, Revenue ($m), Forecast, 2011-2018 35
  • 7.7 Neurostimulation Devices Market, Germany, Revenue ($m), Historic, 2004-2011 36
  • 7.8 Neurostimulation Devices Market, Germany, Revenue ($m), Forecast, 2011-2018 37
  • 7.9 Neurostimulation Devices Market, France, Revenue ($m), Historic, 2004-2011 38
  • 7.10 Neurostimulation Devices Market, France, Revenue ($m), Forecast, 2011-2018 39
  • 7.11 Neurostimulation Devices Market, Italy, Revenue ($m), Historic, 2004-2011 40
  • 7.12 Neurostimulation Devices Market, Italy, Revenue ($m), Forecast, 2011-2018 41
  • 7.13 Neurostimulation Devices Market, Spain, Revenue ($m), Historic, 2004-2011 42
  • 7.14 Neurostimulation Devices Market, Spain, Revenue ($m), Forecast, 2011-2018 43
  • 7.15 Neurostimulation Devices Market, Japan, Revenue ($m), Historic, 2004-2011 44
  • 7.16 Neurostimulation Devices Market, Japan, Revenue ($m), Forecast, 2011-2018 45
  • 7.17 Neurostimulation Devices Market, China, Revenue ($m), Historic, 2004-2011 46
  • 7.18 Neurostimulation Devices Market, China, Revenue ($m), Forecast, 2011-2018 47
  • 7.19 Neurostimulation Devices Market, India, Revenue ($m), Historic, 2004-2011 48
  • 7.20 Neurostimulation Devices Market, India, Revenue ($m), Forecast, 2011-2018 49
  • 7.21 Neurostimulation Devices Market, Australia, Revenue ($m), Historic, 2004-2011 50
  • 7.22 Neurostimulation Devices Market, Australia, Revenue ($m), Forecast, 2011-2018 51
  • 7.23 Neurostimulation Devices Market, Brazil, Revenue ($m), Historic, 2004-2011 52
  • 7.24 Neurostimulation Devices Market, Brazil, Revenue ($m), Forecast, 2011-2018 53

8 Global Neurostimulation Devices Market - Strategic Competitive Assessment 54

  • 8.1 Neurostimulation Devices Market, Global, Company Share (%), 2011 54
  • 8.2 Medtronic 55
    • 8.2.1 Overview 55
    • 8.2.2 Medtronic, Key Marketed Products 57
  • 8.3 St Jude Medical 61
    • 8.3.1 Overview 61
    • 8.3.2 St Jude Medical, Marketed Products 62
  • 8.4 Boston Scientific 64
    • 8.4.1 Overview 64
    • 8.4.2 Boston Scientific, Marketed Products 64
  • 8.5 Cyberonics 65
    • 8.5.1 Overview 65
    • 8.5.2 Cyberonics, Key Marketed Products 65

9 Neurostimulation Devices Market - Pipeline Assessment 67

  • 9.1 Spinal Cord Stimulators, Pipeline Products 68
    • 9.1.1 Algostim Device 68
    • 9.1.2 Genesis Neurostimulation System 69
    • 9.1.3 Nevro Senza System 69
    • 9.1.4 Next Generation Spinal Cord Stimulator System 70
    • 9.1.5 Precision Plus Spinal Cord Stimulation System 70
    • 9.1.6 PrimeADVANCED - Heart Failure 71
    • 9.1.7 Subcutaneous Array of Implantable Neural Transponder System 71
  • 9.2 Deep Brain Stimulators, Pipeline Products 72
    • 9.2.1 Activa PC - Refractory Epilepsy 73
    • 9.2.2 Brio Neurostimulator 73
    • 9.2.3 Coordinated Reset-Capable Implant 74
    • 9.2.4 Deep Brain Stimulation - Alzheimer's Disease 74
    • 9.2.5 Deep Brain Stimulation - Mild Cognitive Impairment 75
    • 9.2.6 Deep Brain Stimulation System - Cachexia 75
    • 9.2.7 Deep Brain Stimulation System - Obesity 76
    • 9.2.8 Deep Brain Stimulation System - Post-Traumatic Stress Disorder 76
    • 9.2.9 Deep Transcranial Magnetic Stimulation System - Alzheimer's Disease 77
    • 9.2.10 Deep Transcranial Magnetic Stimulation System - Autism 77
    • 9.2.11 Deep Transcranial Magnetic Stimulation System - Bipolar Disorder 78
  • 9.3 Sacral Nerve Stimulators, Pipeline Products 78
    • 9.3.1 Sacral Nerve Stimulation Device 78
    • 9.3.2 SAINT System - Urinary Incontinence 79
    • 9.3.3 Verv System - Overactive Bladder 79
  • 9.4 Vagus Nerve Stimulators, Pipeline Products 80
    • 9.4.1 Aspire New Parameters 80
    • 9.4.2 CardioFit System 81
    • 9.4.3 FitNes System - Alzheimer's Disease 81
    • 9.4.4 NEMOS - Epilepsy 82
  • 9.5 Cortical Stimulators, Pipeline Products 82
    • 9.5.1 Cortistim 82
  • 9.6 Other Neurostimulation Devices in the Pipeline 83

10 Neurostimulation Devices Market - Deals Landscape 84

  • 10.1 Neurostimulation Devices Market: Mergers and Acquisitions 84
    • 10.1.1 Sorin Group Invests $7m in Enopace Biomedical 84
    • 10.1.2 Otto Bock Healthcare Acquires Remaining 44.4% Joint Venture Stake in Neurostream Technologies from Victhom Human Bionics 84
    • 10.1.3 Boston Scientific Sells Neurovascular Business Unit to Stryker 85
    • 10.1.4 Vycor Medical Completes Acquisition of NovaVision 85
  • 10.2 Global Neurostimulation Devices Market, Venture Capital Deals 86
    • 10.2.1 Functional Neuromodulation Raises Additional $3m in Venture Financing 87
    • 10.2.2 Nervomatrix Secures $3.5m in Series A Venture Financing 87
    • 10.2.3 Cortec Secures $3.2m in Seed Financing 87
    • 10.2.4 ImThera Medical Secures $4m in Series C Venture Financing 88
    • 10.2.5 Phagenesis Secures $9.3m in Series B Venture Financing 88
    • 10.2.6 Autonomic Technologies Secures $32m in Series C Venture Financing 88
    • 10.2.7 SPR Therapeutics Secures $0.25m in Financing Round 88
    • 10.2.8 Nexstim Secures Additional $2.8m in Venture Financing Round 89
    • 10.2.9 BlueWind Medical Secures Seed Financing 89
    • 10.2.10 Synapse Biomedical Secures $0.43m in Financing Round 89
    • 10.2.11 EBS Technologies Secures $4.4m in Second Round of Financing 89
  • 10.3 Global Neurostimulation Devices Market, Partnership Deals 90
    • 10.3.1 GE Healthcare Enters into a Distribution Agreement with KC BioMedix 90
    • 10.3.2 EndoStim Enters into an Agreement with Arizona State University 90
    • 10.3.3 Ardiem Medical Enters into Licensing Agreement with Case Western Reserve University 91

11 Appendix 92

  • 11.1 Definitions 92
    • 11.1.1 Neurostimulation Devices 92
  • 11.2 Acronyms 93
  • 11.3 Sources 94
  • 11.4 Research Methodology 97
    • 11.4.1 Secondary Research 97
    • 11.4.2 Primary Research 98
    • 11.4.3 Models 98
    • 11.4.4 Forecasts 98
    • 11.4.5 Expert Panels 98
  • 11.5 GlobalData Consulting 99
  • 11.6 Contact Us 99
  • 11.7 Disclaimer 99

List of Tables

1.1 List of Tables

  • Table 1: Ambulatory Surgical Center Medicare Payment for Spinal Cord Stimulation, 2010 vs. 2011 18
  • Table 2: Ambulatory Surgical Center Medicare Payment for Deep Brain Stimulation, 2010 vs. 2011 18
  • Table 3: Ambulatory Surgical Center Medicare Payment for Sacral Nerve Stimulation, 2010 vs. 2011 18
  • Table 4: Medicare Hospital Outpatient Payment for Spinal Cord Stimulation, 2010 vs. 2011 19
  • Table 5: Medicare Hospital Outpatient Payment for Sacral Nerve Stimulation, 2010 vs. 2011 19
  • Table 6: Medicare Hospital Outpatient Payment for Deep Brain Stimulation, 2010 vs. 2011 19
  • Table 7: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011 22
  • Table 8: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018 23
  • Table 9: Healthcare Costs vs. Health-related Quality of Life with Spinal Cord Stimulation and Conventional Medical Management 24
  • Table 10: Incremental Cost-effectiveness of Spinal Cord Stimulation Compared with Conventional Medical Management 25
  • Table 11: Cost Effectiveness, Post-vagus Nerve Stimulation Therapy vs. Pre-vagus Nerve Stimulation Therapy 26
  • Table 12: Example of Neurostimulation Products* through FDA's Fast-track Program 26
  • Table 13: Example of Neurostimulation Products* through FDA's Humanitarian Device Exemption Program 27
  • Table 14: Pipeline Products In Development for New Indications 27
  • Table 15: Neurostimulation Devices Market, The US, Revenue ($m), 2004-2011 30
  • Table 16: Neurostimulation Devices Market, The US, Revenue ($m), 2011-2018 31
  • Table 17: Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011 32
  • Table 18: Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018 33
  • Table 19: Neurostimulation Devices Market, The UK, Revenue ($m), 2004-2011 34
  • Table 20: Neurostimulation Devices Market, The UK, Revenue ($m), 2011-2018 35
  • Table 21: Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011 36
  • Table 22: Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018 37
  • Table 23: Neurostimulation Devices Market, France, Revenue ($m), 2004-2011 38
  • Table 24: Neurostimulation Devices Market, France, Revenue ($m), 2011-2018 39
  • Table 25: Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011 40
  • Table 26: Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018 41
  • Table 27: Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011 42
  • Table 28: Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018 43
  • Table 29: Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011 44
  • Table 30: Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018 45
  • Table 31: Neurostimulation Devices Market, China, Revenue ($m), 2004-2011 46
  • Table 32: Neurostimulation Devices Market, China, Revenue ($m), 2011-2018 47
  • Table 33: Neurostimulation Devices Market, India, Revenue ($m), 2004-2011 48
  • Table 34: Neurostimulation Devices Market, India, Revenue ($m), 2011-2018 49
  • Table 35: Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011 50
  • Table 36: Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018 51
  • Table 37: Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011 52
  • Table 38: Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018 53
  • Table 39: Neurostimulation Devices Market, Global, Company Revenue ($m), 2011 54
  • Table 40: Medtronic, Key Marketed Products*, Neurostimulation Devices 57
  • Table 41: Activa RC, PC and SC Series Neurostimulator, Features and Benefits 58
  • Table 42: Kinetra Neurostimulator, Features and Benefits 58
  • Table 43: Soletra Neurostimulator, Features and Benefits 58
  • Table 44: Restore Series Neurostimulator, Features and Benefits 59
  • Table 45: PrimeAdvanced Neurostimulator, Features and Benefits 59
  • Table 46: Itrel 3 neurostimulator, Features and Benefits 59
  • Table 47: External Trialing System, Features and Benefits 60
  • Table 48: St Jude Medical, Key Marketed Products*, Neurostimulation Devices 62
  • Table 49: Libra Family of Primary Cell IPGs, Features and Benefits 62
  • Table 50: Eon C Primary Cell IPGs, Features and Benefits 63
  • Table 51: Genesis Primary Cell IPG, Features and Benefits 63
  • Table 52: Rechargeable IPGs, Features and Benefits 63
  • Table 53: Boston Scientific, Key Marketed Products*, Neurostimulation Devices 64
  • Table 54: Precision Plus Spinal Cord Stimulation System, Features and Benefits 64
  • Table 55: Cyberonics, Key Marketed Products*, Neurostimulation Devices 65
  • Table 56: VNS Therapy Generator, Features and Benefits 66
  • Table 57: Spinal Cord Stimulators, Pipeline Products 68
  • Table 58: Algostim Device, Product Status 68
  • Table 59: Genesis Neurostimulation System - Chronic Angina, Product Status 69
  • Table 60: Nevro Senza System, Product Status 69
  • Table 61: Next Generation Spinal Cord Stimulator System, Product Status 70
  • Table 62: Precision Plus Spinal Cord Stimulation System, Product Status 70
  • Table 63: PrimeAdvanced - Heart Failure, Product Status 71
  • Table 64: Subcutaneous Array of Implantable Neural Transponder System - Chronic Pain, Product Status 71
  • Table 65: Deep Brain Stimulators, Pipeline Products 72
  • Table 66: Activa PC - Refractory Epilepsy, Product Status 73
  • Table 67: Brio Neurostimulator, Product Status 73
  • Table 68: CR-Capable Implant, Product Status 74
  • Table 69: Deep Brain Stimulation - Alzheimer's Disease, Product Status 74
  • Table 70: Deep Brain Stimulation - Mild Cognitive Impairment, Product Status 75
  • Table 71: Deep Brain Stimulation - Cachexia, Product Status 75
  • Table 72: Deep Brain Stimulation - Obesity, Product Status 76
  • Table 73: Deep Brain Stimulation - Post-Traumatic Stress Disorder 76
  • Table 74: Deep TMS System - Alzheimer's Disease, Product Status 77
  • Table 75: Deep Transcranial Magnetic Stimulation System - Autism, Product Status 77
  • Table 76: Deep Transcranial Magnetic Stimulation System - Bipolar Disorder, Product Status 78
  • Table 77: Sacral Nerve Stimulators, Pipeline Products 78
  • Table 78: Sacral Nerve Stimulation Device, Product Status 78
  • Table 79: SAINT System - Urinary Incontinence, Product Status 79
  • Table 80: Verv System - Overactive Bladder, Product Status 79
  • Table 81: Vagus Nerve Stimulators, Pipeline Products 80
  • Table 82: Aspire NP, Product Status 80
  • Table 83: CardioFit System, Product Status 81
  • Table 84: FitNes System - Alzheimer's Disease, Product Status 81
  • Table 85: NEMOS - Epilepsy, Product Status 82
  • Table 86: Cortical Stimulators, Pipeline Products 82
  • Table 87: Cortistim, Product Status 82
  • Table 88: Other Neurostimulation Devices in the Pipeline 83
  • Table 89: Neurostimulation Devices Market, Mergers and Acquisitions, Global, 2010-2011 84
  • Table 90: Global Neurostimulation Devices Market, Venture Capital Deals 86
  • Table 91: Global Neurostimulation Devices Market, Partnership Deals 90

List of Figures

1.2 List of Figures

  • Figure 1: Neurostimulation Devices, Market Segmentation 20
  • Figure 2: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011 22
  • Figure 3: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018 23
  • Figure 4: Neurostimulation Devices, Regulatory Path for Pipeline Products, 2012 28
  • Figure 5: Neurostimulation Devices Market, The US, Revenue ($m), 2004-2011 30
  • Figure 6: Neurostimulation Devices Market, The US, Revenue ($m), 2011-2018 31
  • Figure 7: Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011 32
  • Figure 8: Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018 33
  • Figure 9: Neurostimulation Devices Market, The UK, Revenue ($m), 2004-2011 34
  • Figure 10: Neurostimulation Devices Market, The UK, Revenue ($m), 2011-2018 35
  • Figure 11: Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011 36
  • Figure 12: Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018 37
  • Figure 13: Neurostimulation Devices Market, France, Revenue ($m), 2004-2011 38
  • Figure 14: Neurostimulation Devices Market, France, Revenue ($m), 2011-2018 39
  • Figure 15: Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011 40
  • Figure 16: Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018 41
  • Figure 17: Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011 42
  • Figure 18: Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018 43
  • Figure 19: Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011 44
  • Figure 20: Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018 45
  • Figure 21: Neurostimulation Devices Market, China, Revenue ($m), 2004-2011 46
  • Figure 22: Neurostimulation Devices Market, China, Revenue ($m), 2011-2018 47
  • Figure 23: Neurostimulation Devices Market, India, Revenue ($m), 2004-2011 48
  • Figure 24: Neurostimulation Devices Market, India, Revenue ($m), 2011-2018 49
  • Figure 25: Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011 50
  • Figure 26: Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018 51
  • Figure 27: Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011 52
  • Figure 28: Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018 53
  • Figure 29: Neurostimulation Devices Market, Global, Company Share* (%), 2011 54
  • Figure 30: Global Neurostimulation Devices, Product Mapping 55
  • Figure 31: Neurostimulation Devices, Analysis of Pipeline Products by Clinical Stage of Development 67
Back to Top